Salivary

Head and Neck Cancer
Salivary
- Locoregionally Advanced/Metastatic
  - HER2-positive
    - 1st line
      - NRGHN010
        PHII Cont/Rand Docetaxel+TH vs T-DMI Recurrent/Metastatic/Tx-Naïve, Unresectable HER2-Positive SGC